Teva-Erlotinib

Generic name

erlotinib hydrochloride

Brand Reference

Tarceva®

Therapeutic Class

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor / Protein Kinase Inhibitor (L01XE03)

Strength

25 mg

DIN

02377691

Product form

Tablet

Colour

white to off-white

Shape

round

Marking 1

93

Marking 2

E2


Teva Erlotinib 25mg

Product Details

Product Code

UPC

Pack Size

71971-0127 068510073273 Blister 30

Ingredients

Please view the product monograph to find details of all ingredients contained in this product.  For additional generic & OTC product inquiries, please call 1-800-268-4127, option 3 or email druginfo@tevacanada.com.


Storage

Store between 15°C - 30°C.


Information

All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.

"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves